Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 14 Relevant Journals, 03 Conferences are presently dedicated exclusively to Hepatitis C Virus and about 954 articles are being published on Hepatitis C Virus.
Hepatitis C Virus small, enveloped single stranded RNA virus belonging to the genus Hepacivirus and the family Flaviridae causes the disease Hepatitis type C. There are seven major genotypes of the virus of which the first is most prevalent in USA and types II and III in other regions of the world. It is a blood borne virus and spread through contact with infected blood. Hepatitis C spreads through usage of insufficiently sterilized medical equipment, long term kidney dialysis, taking intravenous drugs, sexual contact with an infected person, born to an infected mother, organ transplant, blood transfusions, tattooing with unsterilized needles. Diagnosis involves using ELISA for an antibody enzyme immunoassay, Recombinant immunoblot, Quantitative RNA Polymerase chain reaction, elevated liver enzyme levels, blood testing for antibodies and biopsies to test degree of liver damage. World wide there are 130 to 150 billion people infected with the virus.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
Treatment of Hepatitis is on the cutting edge of medicine. Hepatitis B virus infection (HBV) has been recognized as a major health problem worldwide and Hepatitis C virus (HCV) infection is the most common chronic blood borne infection in the United States. Viral hepatitis treatment depends on how active the virus is in your body. Viral hepatitis is the most common cause of hepatitis worldwide. Other causes of non-viral hepatitis include alcoholic hepatitis and autoimmune hepatitis.
Hepatitis C virus is a small with a size of 55–65 nm, enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. Hepatitis C virus is the cause of hepatitis C in humans. The hepatitis C virus is a major public health problem and a leading cause of chronic liver disease. Hepatitis C virus has a positive sense single-stranded RNA genome. This single open reading frame is translated to produce a single protein product, which is then further processed to produce smaller active proteins. The genome consists of a single open reading frame that is 9600 nucleotide bases long. The hepatitis C virus particle consists of a core of genetic material (RNA), surrounded by an icosahedral protective shell of protein, and further encased in a lipid (fatty) envelope of cellular origin.
Market Analysis:
More than 2 000 million people alive today have been infected with HBV at some time in their lives. Of these, about 350 million remain infected chronically and become carriers of the virus. Three quarters of the world’s population live in areas where there are high levels of infection. Every year there are over 4 million acute clinical cases of HBV, and about 25% of carriers, 1 million people a year, die from chronic active hepatitis, cirrhosis or primary liver cancer. High endemicity areas include sub-Saharan Africa, the Middle East, the central Asian Republics, and some countries in eastern Europe. In these areas, about 70 to 90% of the population becomes HBV-infected before the age of 40, and 8 to 20% of people are HBV carriers. In countries such as China, Senegal, and Thailand, infection rates are very high in infants, and continue through early childhood. At that stage the prevalence of HBsAg in serum may exceed 25%. HBV is well studied in Saudi Arabia where the prevalence in the general population is 4.25%. The genotype of the virus D predominates in the Middle East. The highest prevalence (17.5%) of HCV in the world was reported in Egypt. The pooled prevalence of HCV in haemodialysis patients is 16% in Iran, 56% in Saudi Arabia, 52% in Syria, and 34% in Sudan.
5th Virology Conference
December 7-09, 2015 Atlanta, USA
2nd Hepatology Conference
May 09-11, 2016 Chicago, USA
Pancreas Conference
May 12-14, 2016 Chicago, USA
6th Gastroenterology and Gastroenterologists Meeting
June 16-18, 2016 Philadelphia, USA
7th Gastroenterologists Meeting
August 11-12, 2016 Birmingham, UK
Clinical Gastroenterology and Hepatology Conference
October 3-5, 2016 Toronto, Canada
3rd Hepatitis and Liver diseases Conference
October 17-19, 2016 Dubai, UAE
European Gastroenterology Conference
October 24-26, 2016 Valencia, Spain
9th Paris Hepatitis Conference
January 11-12, 2016 Paris, France
Asian pacific Association for the study of the liver 2016
February 20-24, 2016 Tokyo, Japan
International Conference on Gastroenterology, Hepatology and Nutrition
February 25-26, 2016 London, UK
The 51st Annual Meeting of the European Association for the Study of the Liver
April 13- 17, Barcelona, Spain
12th World Congress of the International Hepato-Pancreato-Biliary Association
April 19 – 23, 2016, Sao Paolo, Brazil
International Liver Transplantation Society Annual International Congress
May 4 – 7, 2016, Seoul, South Korea
18th International Conference on Hepatology and Liver Disease
May 23 – 24, 2016, London, UK
Prague Hepatology Meeting 2016
September 22 – 24, 2016 Prague, Czech
World Congress of Pediatric Gastroenterology, Hepatology and Nutrition
October 4 – 10, 2016 Montreal, Canada
18th International Conference on Viral Hepatitis
December 12-13, 2016 Bangkok, Thailand
List of Societies and Associations:
List of Companies:
This page will be updated regularly.
This page was last updated on November 25, 2024
